NCB-0846

N/A

Report date: 2022/10/21 15:47:21
NME

Base Information

Drug NameNCB-0846
Drug Alias NameNCB-0846
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionWnt signalling pathway inhibitorsTRAF2 and NCK-interacting protein kinase inhibitors
TargetsTRAF2 and NCK-interacting protein kinase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCarna Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesCarna Biosciences Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A